Growth Differentiation Factor-15 as a Predictor of Functional Capacity, Frailty, and Ventricular Dysfunction in Patients With Aortic Stenosis and Preserved Left Ventricular Ejection Fraction
Lauren Basmadjian(Montreal Heart Institute), Christine Henri(Montreal Heart Institute), Eileen O’Meara(Montreal Heart Institute), Normand Racine(Montreal Heart Institute), Michel White(Montreal Heart Institute), Raymond Cartier(Montreal Heart Institute), François Simard(Montreal Heart Institute), Jean‐François Dorval(Montreal Heart Institute), Nadia Bouabdallaoui(Montreal Heart Institute), Martin G. Sirois(Montreal Heart Institute), Jessica Forcillo(Montreal Heart Institute), Jean‐Lucien Rouleau(Montreal Heart Institute), Raoul Bonan(Montreal Heart Institute), Réda Ibrahim(Université de Montréal), Anique Ducharme(Montreal Heart Institute), Ismaı̈l El-Hamamsy(Mount Sinai Hospital), Anita Asgar(Montreal Heart Institute)
Cited by 6
Related Papers
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
Valsartan, Captopril, or Both in Myocardial Infarction Complicated by Heart Failure, Left Ventricular Dysfunction, or Both
|New England Journal of Medicine|2003|2.5k
Relation between Renal Dysfunction and Cardiovascular Outcomes after Myocardial Infarction
|New England Journal of Medicine|2004|1.9k
Rhythm Control versus Rate Control for Atrial Fibrillation and Heart Failure
|New England Journal of Medicine|2008|1.6k